Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra

SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company.

In this new position Syburra will be leveraging all business intelligence for Medical Marijuana, Inc. and subsidiary companies including HempMeds® and Kannaway. He will oversee all the data received through multiple revenue channels, analyze it and then help determine the best way to manage and leverage the data, with the goal of using it to expand the company. He will also oversee all technology systems.

Syburra has played a vital role as part of the Medical Marijuana, Inc. team since 2012, where he has helped to educate staff on IT matters and update the company’s technology systems. Previously, Syburra was a General Manager for New Horizons Computer Learning Center where he oversaw computer learning programs to help individuals update their technology advances.

“We are thrilled to have Dirk Syburra promoted to this new position as the Vice President of Data & Technology and are looking forward to having him further develop the company’s data analytics and tracking,” said Medical Marijuana, Inc.  Chief Executive Officer, Dr. Stuart Titus. “We know that with his impressive background of data intelligence and operations he can further expand our company in this era where leveraging technology is crucial to increasing revenue.”

“I am excited about taking on this new responsibility for a company that I fully believe in, and I look forward to further expanding the company using the tremendous data and technology that is available,” said Dirk Syburra, Vice President of Data & Technology, Medical Marijuana, Inc.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 888-829-0070

[email protected]

Corporate Business Contact:

Medical Marijuana, Inc.

OTC Symbol: MJNA

Toll Free: 888-OTC-MJNA (888-682- 6562)

Investor Relations Contact:

EquiNet, LLC

Toll Free: (877) 964.6463

Office/Direct: (858) 264-6500

Email: [email protected]